Breakthrough infection of Trichosporon asahii during posaconazole treatment in a patient with acute myeloid leukaemia.
A neutropenic patient with acute myeloid leukaemia experienced a breakthrough infection of Trichosporon asahii during posaconazole treatment. After treatment was changed to a combination therapy with voriconazole and liposomal amphotericin B, the infection resolved. Posaconazole works effectively as an antifungal prophylaxis and salvage therapy in rare invasive fungal infections. This case however illustrates that breakthrough infections with T. asahii may occur during posaconazole treatment.
Rieger
C
C
Department of Hematology/Oncology, University Hospital Grosshadern, Ludwig Maximilian University, Marchioninistrasse 15, 81377, Munich, Germany. christina.rieger@med.uni-muenchen.de
Geiger
S
S
Herold
T
T
Nickenig
C
C
Ostermann
H
H
D000368:Aged; D000666:Amphotericin B / Q000627:therapeutic use; D000935:Antifungal Agents / Q000627:therapeutic use; D003428:Cross Infection / Q000188:drug therapy / Q000382:microbiology*; D004359:Drug Therapy, Combination; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000150:complications*; D008297:Male; D009181:Mycoses / Q000188:drug therapy / Q000382:microbiology*; D011743:Pyrimidines / Q000627:therapeutic use; D014230:Triazoles / Q000627:therapeutic use*; D014250:Trichosporon / Q000187:drug effects* / Q000302:isolation & purification*; D065819:Voriconazole
D000935:Antifungal Agents; D011743:Pyrimidines; D014230:Triazoles; C068538:liposomal amphotericin B; C101425:posaconazole; D000666:Amphotericin B; D065819:Voriconazole
Antimicrob Agents Chemother. 2002 Apr;46(4):1144-6
11897610
N Engl J Med. 2007 Jan 25;356(4):335-47
17251530
Support Care Cancer. 1999 Jan;7(1):39-43
9926973
Clin Infect Dis. 2006 Oct 15;43(8):1060-8
16983621
Scand J Infect Dis. 2004;36(8):564-9
15370667
Clin Infect Dis. 2007 Jan 1;44(1):2-12
17143808
Eur J Clin Microbiol Infect Dis. 2002 Dec;21(12):892-6
12525928
N Engl J Med. 2007 Jan 25;356(4):348-59
17251531
Antimicrob Agents Chemother. 2006 Oct;50(10):3269-76
17005804
Clin Infect Dis. 1992 Nov;15(5):781-7
1445976